Na Cai (Chair) , Andrew Schork (Co-chair) , Jonathan Flint (Discussant)
{"title":"HETEROGENEITY AND COMORBIDITY: PERSPECTIVES FROM BIOBANKS, REGISTRIES AND EHRS","authors":"Na Cai (Chair) , Andrew Schork (Co-chair) , Jonathan Flint (Discussant)","doi":"10.1016/j.euroneuro.2024.08.074","DOIUrl":null,"url":null,"abstract":"<div><div>Large-scale, population-based biobanks, electronic health records (EHRs) and medical registries have been transformative for psychiatric genetics research through providing unprecedented sample sizes. Critically, many of these resources are also providing longitudinal data across an expanding timeline from which the life-course of individual patients can be surveyed. The view is a complex one - varying recurrence, intervals between episodes, treatment experiences, comorbidities, secondary outcomes, and disease trajectories. In short, we observe an immense amount of variability across dataset and individuals. This creates a new opportunity to systematically interrogate if using diverse and nuanced descriptions of individual cases can impact on the genetic findings of underlying architecture of psychiatric disorders. In this symposium, we bring together researchers providing different perspectives and research angles interrogating the complex data from the UKBiobank, iPSYCH, Danish Blood Donors/Copenhagen Hospital Biobank, the Danish Health Registries, Swedish Health Registries, and the BioVu EHR. First, Lu Yi will describe her work using co-sibling analysis in the Swedish Health Registries to describe multiple clinical features of major depression that impact on its genetic architecture. Second, Sarah Guagliardo will dive into the sex-specific heterogeneity in ADHD using Vanderbilt University's BioVu EHR. Third, Jolien Rietkerk will systematically describe variability in polygenic profiles associated with pairwise comorbidity of five major psychiatric disorders using data from the UKBiobank and iPSYCH. Finally, Mischa Lundberg will describe how variations in biobank sampling schema and inclusion/exclusion criteria can impact on the genetic profiles of major depression cases across biobanks, EHRs, and medical registries. Jonathan Flint will discuss this work in the context of ongoing and future directions in psychiatric genetics. This symposium will provide an overview of the complexities and opportunities presented by larger and larger data resources with deeper and broader assessments.</div></div>","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"87 ","pages":"Pages 29-30"},"PeriodicalIF":6.1000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Neuropsychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0924977X24002736","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Large-scale, population-based biobanks, electronic health records (EHRs) and medical registries have been transformative for psychiatric genetics research through providing unprecedented sample sizes. Critically, many of these resources are also providing longitudinal data across an expanding timeline from which the life-course of individual patients can be surveyed. The view is a complex one - varying recurrence, intervals between episodes, treatment experiences, comorbidities, secondary outcomes, and disease trajectories. In short, we observe an immense amount of variability across dataset and individuals. This creates a new opportunity to systematically interrogate if using diverse and nuanced descriptions of individual cases can impact on the genetic findings of underlying architecture of psychiatric disorders. In this symposium, we bring together researchers providing different perspectives and research angles interrogating the complex data from the UKBiobank, iPSYCH, Danish Blood Donors/Copenhagen Hospital Biobank, the Danish Health Registries, Swedish Health Registries, and the BioVu EHR. First, Lu Yi will describe her work using co-sibling analysis in the Swedish Health Registries to describe multiple clinical features of major depression that impact on its genetic architecture. Second, Sarah Guagliardo will dive into the sex-specific heterogeneity in ADHD using Vanderbilt University's BioVu EHR. Third, Jolien Rietkerk will systematically describe variability in polygenic profiles associated with pairwise comorbidity of five major psychiatric disorders using data from the UKBiobank and iPSYCH. Finally, Mischa Lundberg will describe how variations in biobank sampling schema and inclusion/exclusion criteria can impact on the genetic profiles of major depression cases across biobanks, EHRs, and medical registries. Jonathan Flint will discuss this work in the context of ongoing and future directions in psychiatric genetics. This symposium will provide an overview of the complexities and opportunities presented by larger and larger data resources with deeper and broader assessments.
期刊介绍:
European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.